Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06907524 · ClinicalTrials.gov registry record · NA
Preventative Screening and Health Coaching in a Food Insecure Population
A NA study, sponsored by Rush University Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT06907524: Clinical Trial NA study, sponsored by Rush University Medical Center.
NCT06907524 is a NA study that has not yet begun recruiting, run by Rush University Medical Center. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06907524, a NA study, has not yet begun recruiting, sponsored by Rush University Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The goal of this longitudinal study is to investigate the role of virtual health coaching on mitigation of cardiometabolic disease risk in an underserved, food insecure population. The main questions it aims to answer are: * Does longitudinal, individualized health coaching directed at lifestyle modification reduce patient 10-year risk of heart attack or stroke? * Does longitudinal, individualized health coaching directed at lifestyle modification reduce rates of hypertension, hyperlipidemia, and diabetes? * Does longitudinal, individualized health coaching directed at lifestyle modification improve accessibility to healthcare? Researchers will investigate the effects of regularly scheduled health coaching sessions on composite cardiometabolic risk profile as well as individual modifiable cardiovascular risk factors. Participants will: * Participate in in-person cardiovascular screening, occuring at the time of enrollment, months 3 and 6. * Engage in virtual health coaching sessions to talk about diet, exercise, weight loss, blood pressure and diabetes control, and accessibility to healthcare * Keep a log of their blood pressure
Primary Outcome
Study data collected during in-person screening - occuring at the initial screening, 3 and 6 month rescreening - will be utilized to calculate the patient's 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk via the MD+ Calc ASCVD risk calculator from the American Heart Association (AHA)/American College of Cardiology (ACC).
Interventions
- BEHAVIORAL Longitudinal, Individualized Health Coaching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What is known before NCT06907524 opens enrollment
NCT06907524 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Longitudinal, Individualized Health Coaching is the first listed.
NCT06907524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06907524 about?
NCT06907524 is a clinical study titled "Preventative Screening and Health Coaching in a Food Insecure Population". The goal of this longitudinal study is to investigate the role of virtual health coaching on mitigation of cardiometabolic disease risk in an underserved, food insecure population. The main questions it aims to answer are: * Does longitudinal, individualized health coaching directed at lifestyle mo...
What is the current status of trial NCT06907524?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-04-01. Estimated completion is 2027-07-01.
What interventions are being tested in trial NCT06907524?
The interventions under investigation include: Longitudinal, Individualized Health Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT06907524?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06907524's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI